| Log in
Pfizer

Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B

11 September, 2012

Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), th ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Strides Arcolab promoters may sell their entire stake for $540M, Pfizer front-runner

Strides Arcolab promoters may sell their entire stake for $540M, Pfizer front-runner

Pooja Sarkar 5 years ago
Promoters of Strides Arcolab Ltd, who were earlier involved in negotiations for...
Strides Arcolab buying Shasun Pharma in all stock deal worth over $221M

Strides Arcolab buying Shasun Pharma in all stock deal worth over $221M

Jasleen Kaur Batra 3 years ago
Bangalore-based Strides Arcolab Ltd, which sold its injectable-medicine unit...
Strides Arcolab Buys Star Drugs’ Sterile Formulations Plant For $23.8M

Strides Arcolab Buys Star Drugs’ Sterile Formulations Plant For $23.8M

Bhawna Gupta 6 years ago
Strides Arcolab Ltd has acquired a US FDA approved sterile formulations facility...
No Comments

Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B

Powered by WordPress.com VIP